Mode
Text Size
Log in / Sign up
N/A N=64 Randomized Triple-blind Treatment

Attention Bias Modification Training for Child Anxiety CBT Nonresponders

Anxiety Disorders

Enrolled (actual)
64
Serious AEs
1.6%
Results posted
Aug 2017
Primary outcome: Primary: Clinician Rating on the Pediatric Anxiety Rating Scale — 8.88; 8.12 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Attention Bias Modification (Behavioral); Placebo Attention Task (Behavioral)
Age
Pediatric · 8+ yrs
Sex
All
Sponsor
Florida International University
Primary completion
Jun 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Clinician Rating on the Pediatric Anxiety Rating Scale
9.50; 5.95
PRIMARY
Clinician Rating on the Pediatric Anxiety Rating Scale
9.50; 5.95
SECONDARY
Screen for Child Anxiety Related Emotional Disorders - Parent Version
21.05; 17.98
SECONDARY
Screen for Child Anxiety Related Emotional Disorders - Child Version
17.75; 12.09
SECONDARY
Screen for Child Anxiety Related Emotional Disorders - Parent Version
21.05; 17.98
SECONDARY
Screen for Child Anxiety Related Emotional Disorders - Child Version
17.75; 12.09

Summary

This project will test Attention Bias Modification Training (ABMT) among children and adolescents who have completed a full protocol of cognitive behavior therapy (CBT) for anxiety and still meet criteria for a primary diagnosis of an anxiety disorder. The purpose of this project is to determine whether ABMT leads to reductions in anxiety and related impairment, relative to a placebo task condition.

Eligibility Criteria

Inclusion Criteria

  • 8-16 years old
  • completed a 12-14 week cognitive behavioral therapy for anxiety
  • a primary DSM-IV diagnosis of generalized anxiety disorder, social anxiety disorder, or separation anxiety disorder
  • if other psychiatric disorders are present, they must be treated with medication and stable

Exclusion Criteria

  • meet diagnostic criteria for Organic Mental Disorders, Psychotic Disorders, Pervasive Developmental Disorders, or Mental Retardation
  • a high likelihood of harming self or others
  • not been living with a primary caregiver for at least 6 months who is legally able to give consent for the child's participation
  • previously undisclosed abuse requiring investigation or ongoing supervision by the Department of Social Services;
  • involved currently in another psychosocial/behavioral treatment
  • a serious vision problem that is not corrected with prescription lenses
  • a physical disability that interferes with the ability to click a mouse button rapidly and repeatedly
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01819311). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search